| Nr. | Year OPEN | Title | users say | rate good | rate bad | no link | Citation |
|---|
Hepatorenal syndromeTerlipressinCAMPGlucagonPhosphorousKidney (Hyperfiltration)Transporter (Sodium and phosphate)Receptor (cAMP extracellular)| 1 | 1978 | Kidney failure in liver disease. | 
| + | - | nl | Br Med J 1(6124):1375-6 (1978) |
| 2 | 2010 | Hepatorenal syndrome. |
| + | - | nl | South Med J 103(7):654-61 (2010) |
| 3 | 2001 | Current management and novel therapeutic strategies for refractory ascites and hepatorenal syndrome. |
| + | - | nl | QJM 94(6):293-300 (2001) |
| 4 | 2003 | Hepatorenal syndrome. |
| + | - | nl | Ann Hepatol 2(1):23-9 (2003) |
| 5 | 2006 | Hepatorenal syndrome: pathophysiology and management. |
| + | - | nl | Clin J Am Soc Nephrol 1(5):1066-79 (2006) |
| 6 | 2007 | Systematic review: renal and other clinically relevant outcomes in hepatorenal syndrome trials. |
| + | - | nl | Aliment Pharmacol Ther 25(9):1017-28 (2007) |
| 7 | 2006 | Meta-analysis: terlipressin therapy for the hepatorenal syndrome. |
| + | - | nl | Aliment Pharmacol Ther 24(6):935-44 (2006) |
| 8 | 2005 | Review article: current management of renal dysfunction in the cirrhotic patient. |
| + | - | nl | Aliment Pharmacol Ther 21(8):949-61 (2005) |
| 9 | 2004 | Review article: hepatic hydrothorax. |
| + | - | nl | Aliment Pharmacol Ther 20(3):271-9 (2004) |
| 10 | 2000 | Review article: pharmacological treatment of the hepatorenal syndrome in cirrhotic patients. |
| + | - | nl | Aliment Pharmacol Ther 14(5):515-21 (2000) |
| 11 | 2001 | The hepatorenal syndrome. |
| + | - | nl | Gut 49(5):729-37 (2001) |
| 12 | 1972 | Renal changes in cirrhosis. |
| + | - | nl | Gut 13(9):748-53 (1972) |
| 13 | 2007 | Acute renal dysfunction in liver diseases. |
| + | - | nl | World J Gastroenterol 13(42):5552-9 (2007) |
| 14 | 2007 | Hepatorenal syndrome. |
| + | - | nl | World J Gastroenterol 13(30):4046-55 (2007) |
| 15 | 2006 | Cardiopulmonary complications in chronic liver disease. |
| + | - | nl | World J Gastroenterol 12(4):526-38 (2006) |
| 16 | 2006 | Progress in treatment of massive ascites and hepatorenal syndrome. |
| + | - | nl | World J Gastroenterol 12(4):516-9 (2006) |
| 17 | 2008 | Acute kidney injury in cirrhosis. |
| + | - | nl | Hepatology 48(6):2064-77 (2008) |
| 18 | 2001 | New challenge of hepatorenal syndrome: prevention and treatment. |
| + | - | nl | Hepatology 34(6):1242-51 (2001) |
| 19 | 1996 | Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis. International Ascites Club. |
| + | - | nl | Hepatology 23(1):164-76 (1996) |
| 20 | 1999 | Hepatorenal syndrome. |
| + | - | nl | J Am Soc Nephrol 10(8):1833-9 (1999) |
| 21 | 1994 | Hepatorenal syndrome: emerging perspectives of pathophysiology and therapy. |
| + | - | nl | J Am Soc Nephrol 4(10):1735-53 (1994) |
| 22 | 1993 | Hepatorenal syndrome. |
| + | - | nl | Kidney Int 43(3):737-53 (1993) |
| 23 | 2010 | Terlipressin and hepatorenal syndrome: what is important for nephrologists and hepatologists. |
| + | - | nl | World J Gastroenterol 16(41):5139-47 (2010) |
| 24 | 2007 | Hepatorenal syndrome: current diagnostic and therapeutic concepts. |
| + | - | nl | Nephrol Dial Transplant 22 Suppl 8(-):viii2-viii4 (2007) |
| 25 | 2010 | Renal dysfunction in chronic liver disease. |
| + | - | nl | Crit Care 14(2):214 (2010) |
| 26 | 2004 | Renal dysfunction in cirrhosis: diagnosis, treatment and prevention. |
| + | - | nl | MedGenMed 6(4):9 (2004) |
| 27 | 2002 | Extracellular cAMP inhibits proximal reabsorption: are plasma membrane cAMP receptors involved? |
| + | - | nl | Am J Physiol Renal Physiol 282(3):F376-92 (2002) |
